High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study
- PMID: 17526555
- DOI: 10.1136/ard.2006.068247
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study
Abstract
Objectives: New effective therapies with particularly good effect on joint destruction have highlighted the need for reliable predictors of radiographic progression in rheumatoid arthritis (RA). Our objective was to assess the combined predictive role of a set of laboratory markers with regard to 10-year radiographic progression, and to examine the effect of anti-cyclic citrullinated peptide (anti-CCP) level.
Methods: A cohort of 238 patients with RA was followed longitudinally for 10 years with the collection of clinical data and serum samples. 125 patients with radiographs of the hands available at both baseline and after 10 years were included in this study. Radiographs were scored according to the van der Heijde modified Sharp score. Baseline sera were analysed for C-reactive protein, erythrocyte sedimentation rate (ESR), anti-CCP, IgA rheumatoid factor (RF) and IgM RF. Logistic regression analyses were used to identify predictors of radiographic progression and to examine the effect of anti-CCP level.
Results: Anti-CCP (OR 4.0; 95% CI 1.6 to 10.0) was the strongest independent predictor of radiographic progression. Female gender (OR 3.3; 95% CI 1.3 to 7.6), high ESR (OR 3.2; 95% CI 1.2 to 7.6) and a positive IgM RF (OR 3.1; 95% CI 1.2 to 7.9) were also independent predictors. Compared with the anti-CCP-negative patients, patients with low to moderate levels of anti-CCP (OR 2.6; 95% CI 0.9 to 7.2) and patients with high levels of anti-CCP (OR 9.9; 95% CI 2.7 to 36.7) were more likely to develop radiographic progression.
Conclusions: Anti-CCP, IgM RF, ESR and female gender were independent predictors of radiographic progression and could be combined into an algorithm for better prediction. Patients with high levels of anti-CCP were especially prone to radiographic progression, indicating that the anti-CCP level may add prognostic information.
Similar articles
-
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.Ann Rheum Dis. 2006 Apr;65(4):453-8. doi: 10.1136/ard.2005.041376. Epub 2005 Sep 21. Ann Rheum Dis. 2006. PMID: 16176994 Free PMC article.
-
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.Ann Rheum Dis. 2003 Feb;62(2):120-6. doi: 10.1136/ard.62.2.120. Ann Rheum Dis. 2003. PMID: 12525380 Free PMC article.
-
Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study.BMJ Open. 2014 Jul 30;4(7):e005246. doi: 10.1136/bmjopen-2014-005246. BMJ Open. 2014. PMID: 25079933 Free PMC article. Clinical Trial.
-
Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis.Ann Intern Med. 2007 Jun 5;146(11):797-808. doi: 10.7326/0003-4819-146-11-200706050-00008. Ann Intern Med. 2007. PMID: 17548411 Review.
-
Poor prognostic factors and unmet needs in rheumatoid arthritis.Rheumatology (Oxford). 2025 Mar 1;64(Supplement_2):ii3-ii8. doi: 10.1093/rheumatology/keae701. Rheumatology (Oxford). 2025. PMID: 39798131 Free PMC article. Review.
Cited by
-
A Transmembrane Polymorphism of Fcγ Receptor IIb Is Associated with Kidney Deficiency Syndrome in Rheumatoid Arthritis.Evid Based Complement Alternat Med. 2016;2016:3214657. doi: 10.1155/2016/3214657. Epub 2016 Mar 8. Evid Based Complement Alternat Med. 2016. PMID: 27051449 Free PMC article.
-
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.Arthritis Res Ther. 2016 Oct 6;18(1):226. doi: 10.1186/s13075-016-1116-9. Arthritis Res Ther. 2016. PMID: 27716332 Free PMC article.
-
Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.PLoS One. 2018 Aug 17;13(8):e0202583. doi: 10.1371/journal.pone.0202583. eCollection 2018. PLoS One. 2018. PMID: 30118518 Free PMC article.
-
Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort.Arthritis Res Ther. 2009;11(5):R146. doi: 10.1186/ar2820. Epub 2009 Oct 1. Arthritis Res Ther. 2009. PMID: 19796386 Free PMC article.
-
Anti-Citrullinated Protein Antibody Titers Are Independently Modulated by Both Disease Activity and Conventional or Biologic Anti-Rheumatic Drugs.Diagnostics (Basel). 2022 Jul 21;12(7):1773. doi: 10.3390/diagnostics12071773. Diagnostics (Basel). 2022. PMID: 35885675 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous